Trump picks White House aide Dr. Heidi Overton for top FDA job
Trump nominated Overton to be the next commissioner of the Food and Drug Administration.
ABC News2 sources
Published by CurrentWire · First coverage · Latest coverage
Compiled by CurrentWire News Desk
Summary based on reporting from ABC News and The Hill.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
2 publications are covering this story.
Excerpts are the summaries each publisher distributes with its own feed, shortened and attributed.
ABC NewsTier B
Trump picks White House aide Dr. Heidi Overton for top FDA job(opens original report in a new tab)The HillTier B
Trump taps White House adviser Heidi Overton to lead FDA(opens original report in a new tab)President Trump tapped Dr. Heidi Overton to be his new Food and Drug Administration (FDA) commissioner, he announced Wednesday on Truth Social. Overton, a physician, is a top White House domestic policy adviser on… — The Hill
How coverage developed
First report from The Hill
Story updateHeadline updated
Story updateABC News joined coverage
Story updateCoverage went from 1 to 2 sources
Reported by ABC News
How CurrentWire compiled this story
ABC News (abcnews.com), a Tier B publisher, filed this report on . CurrentWire published this page 5 minutes later, on .
Signal breakdown
CurrentWire ranked this story 82.3 of 100 in the snapshot this page was rendered from.
- Freshness
- 34.8 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 8.5 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 10 of 10
- Velocity
- 5 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Politics · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: White House (11), FDA (4), Heidi Overton (4).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.